Yep, I don't reckon they'd get out of the room in one peice, especially the original ones who made such a mess of valuations. Anyone know where any of these astute professionals are working now by chance?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025